Research Areas

In ths section, by  far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.

Items 1 to 15 of 21 total

per page
Page:
  1. 1
  2. 2
Axon ID Name Description From price
1779 WP 1130 Deubiquitinase Inhibitor €95.00
2991 USP7-USP47 inhibitor Selective inhibitor of deubiquitinase USP7 and USP47  Recently added €90.00
2333 TCID Potent inhibitor of UCHL3 with >100-fold selectivity over UCHL1 €80.00
2512 Spautin 1 Inhibitor of USP10 and USP13 and Beclin1 related autophagy €95.00
1904 SMER 3 Inhibitor of an SCF family E3 Ubiquitin ligase €90.00
1953 PRT 4165 E3 Ubiquitin ligase Bmi1/Ring1A inhibitor €70.00
1906 P 22077 Inhibitor of deubiquitinase USP7 and USP47 €95.00
2011 P 005091 Inhibitor of deubiquitinase USP7 and USP47 €95.00
2199 ONX 0914 Selective inhibitor of LMP7 subunit of the immunoproteasome. €95.00
2228 NSC 687852 Inhibitor of 19S regulatory-particle–associated deubiquitinases (DUBs: UCHL5 and USP14) €90.00
2565 N106 Activator of E1 ligase mediated SERCA2a SUMOylation €95.00
2557 MLN 9708 Citrate prodrug of MLN 2238, selective and reversible 20S proteasome inhibitor €95.00
2556 MLN 2238 Selective and reversible 20S proteasome inhibitor €85.00
2678 ML364 Inhibitor of the deubiquitinase USP2 €125.00
2995 ML 367 Inhibitor of ATAD5 stabilization  Recently added €125.00

Items 1 to 15 of 21 total

per page
Page:
  1. 1
  2. 2
Please wait...